Research Area(s): Glaucoma Harvard Medical School Co-Director, Glaucoma Center of Excellence Mass. Eye and Ear Director, Glaucoma ServiceAlbert and Diane Kaneb Chair in Ophthalmology Profiles: Harvard Catalyst Profile Mass. Eye and Ear Profile (Research) Mass. Eye and Ear Profile (Clinical)
Primary Acquired Nasolacrimal Duct Obstruction (PANDO) PANDO is a condition in which chronic inflammation and scarring block the tear drainage system without another identifiable cause for the obstruction, such as trauma, tumor, etc. Patients with PANDO usually seek help when tears overflow...
In this issue of eye Insights, we take a close look at idiopathic intracranial hypertension (IIH). You'll find key information about how IIH is diagnosed and treated. Inside: Message from the Editor-in-Chief What is Idiopathic Intracranial Hypertension? How is a Patient Diagnosed? What are the...
Dear Colleagues, In this issue of eye Insights, we take a close look at idiopathic intracranial hypertension (IIH). Inside, you’ll find key information about how IIH is diagnosed and treated as well as further reading. IIH is becoming more prevalent due to increasing rates of obesity in the United...
Acetazolamide The first-line medical therapy is acetazolamide, which reduces CSF production by the choroid plexus. In the recent IIH Treatment Trial, acetazolamide, in addition to weight loss, was found to be more effective than weight loss alone in patients with IIH and mild visual loss. The...
Nearly half of Americans who currently have glaucoma are unaware of their condition. Why? Most types of glaucoma are painless, with no feelings of discomfort. Glaucoma typically affects peripheral vision first, so many people remain unaware of the disease until their central vision is affected...